Is the placement of jejunostomy tubes in patients with esophageal cancer undergoing esophagectomy associated with increased inpatient healthcare utilization? An analysis of the National Readmissions Database - 08/12/20
, Arturo J. Rios-Diaz a, Spencer Liem a, Courtney L. Devin a, Nathaniel R. Evans a, Ernest L. Rosato a, Francesco Palazzo a, Adam C. Berger bAbstract |
Background |
Patients undergoing esophagectomy often receive jejunostomy tubes (j-tubes) for nutritional supplementation. We hypothesized that j-tubes are associated with increased post-esophagectomy readmissions.
Study design |
We identified esophagectomies for malignancy with (EWJ) or without (EWOJ) j-tubes using the 2010–2015 Nationwide Readmissions Database. Outcomes include readmission, inpatient mortality, and complications. Outcomes were compared before and after propensity score matching (PSM).
Results |
Of 22,429 patients undergoing esophagectomy, 16,829 (75.0%) received j-tubes. Patients were similar in age and gender but EWJ were more likely to receive chemotherapy (24.2% vs. 15.1%, p < 0.01). EWJ was associated with decreased 180-day inpatient mortality (HR 0.72 [0.52–0.99]) but not with higher readmissions at 30- (15.2% vs. 14.0%, p = 0.16; HR 0.9 [0.77–1.05]) or 180 days (25.2% vs. 24.3%, p = 0.37; HR 0.94 [0.79–1.10]) or increased complications (p = 0.37). These results were confirmed in the PSM cohort.
Conclusion |
J-tubes placed in the setting of esophagectomy do not increase inpatient readmissions or mortality.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Jejunostomy tubes placed at the time of esophagectomy do not decrease postoperative complications or readmissions. |
• | Patients undergoing esophagectomy with jejunostomy tube placement are at lower risk for inpatient mortality. |
• | Jejunostomy tube-related complications are a relatively rare cause of inpatient readmission after esophagectomy. |
Keywords : Jejunostomy tube, Feeding catheter, Esophagectomy, Esophageal cancer, National Readmissions Database
Plan
Vol 221 - N° 1
P. 141-148 - janvier 2021 Retour au numéro
Article précédent
- Preoperative cholangitis is an independent risk factor for mortality in patients after pancreatoduodenectomy for pancreatic cancer
- Eli P. Darnell, Thomas J. Wang, Melissa A. Lumish, Yasmin G. Hernandez-Barco, Maximilian Weniger, Brenna W. Casey, Motaz Qadan, Keith D. Lillemoe, Cristina R. Ferrone, C. Fernandez-Del Castillo, Kumar Krishnan
- Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer
- Makoto Sakai, Makoto Sohda, Hideyuki Saito, Yasunari Ubukata, Nobuhiro Nakazawa, Kengo Kuriyama, Keigo Hara, Akihiko Sano, Kyoichi Ogata, Takehiko Yokobori, Ken Shirabe, Hiroshi Saeki
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?